India to Kenya: Kit Export Trade Route

The India to Kenya Kit corridor is one of India's established pharmaceutical export routes, with 721 shipments documented worth a combined $17.7M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 20% of all export value, reflecting the consolidated nature of India's kit manufacturing sector.

Across 117 active suppliers, the average shipment value stands at $24.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with kit's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 10.9%, placing it at rank #17 among India's top kit export destinations globally.

On the import side, key buyers of Indian kit in Kenya include KENYA MEDICAL SUPPLIES AGENCY, THE MANAGER,, CIPLA KENYA LTD C/O IMPERIAL MANAGE and 173 others. KENYA MEDICAL SUPPLIES AGENCY is the single largest importer with 16 shipments valued at $3.5M USD.

India's kit exports to Kenya are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 14 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 117 active exporters signals a competitive but concentrated market — buyers in Kenya benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED, AFROWAY PHARMA, LUPIN LIMITED — together account for 56% of total trade value on this route. The average shipment value of $24.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as esclam kit(amoxicillin 1000mg tablets,clarithromycin 500mg & esomeprazole 20mg dr tablets)[ps:7x1x6x10100pac=424200 nos] and stop tb cat i & iii patient kit-agdf rifampicin 150mg+isoniazide 75mg+pyrazinamide 400mg+ethambutol 275mg, suggesting that buyers in Kenya tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, KENYA MEDICAL SUPPLIES AGENCY is the largest importer with 16 shipments worth $3.5M USD — representing 20% of all kit imports from India on this route. A total of 176 buyers are active on this corridor.